Remoxipride
- CAS No.
- 80125-14-0
- Chemical Name:
- Remoxipride
- Synonyms
- Roxiam;FLA-731;A-33547;REMOXIPRIDE;(S)-Remoxipride;Remoxipride [USAN:BAN:INN];(S)-3-Bromo-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2，6-dimethoxybenzamide;(S)-3-BroMo-N-((1-ethylpyrrolidin-2-yl)Methyl)-2,6-diMethoxybenzaMide;3-Bromo-2,6-dimethoxy-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]benzamide;3-Bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2,6-dimethoxybenzamide
- CBNumber:
- CB2493967
- Molecular Formula:
- C16H23BrN2O3
- Molecular Weight:
- 371.27
- MDL Number:
- MFCD00869705
- MOL File:
- 80125-14-0.mol
| alpha | D20 -64° (c = 2 in ethanol) |
|---|---|
| Boiling point | 439.9±45.0 °C(Predicted) |
| Density | 1.292 |
| storage temp. | 2-8°C |
| pka | pKa 8.9 (Uncertain) |
| CAS DataBase Reference | 80125-14-0(CAS DataBase Reference) |
| FDA UNII | 0223RD59PE |
| NIST Chemistry Reference | Remoxipride(80125-14-0) |
| ATC code | N05AL04 |
Remoxipride price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | API0009206 | REMOXIPRIDE 95.00% | 80125-14-0 | 1G | $1725.15 | 2021-12-16 | Buy |
| Chemenu | CM197831 | (S)-3-bromo-N-((1-ethylpyrrolidin-2-yl)methyl)-2,6-dimethoxybenzamide 95% | 80125-14-0 | 1g | $893 | 2021-12-16 | Buy |
| AHH | MT-58413 | Remoxipride 98% | 80125-14-0 | 0.1g | $910 | 2021-12-16 | Buy |
| Crysdot | CD31000764 | Remoxipride 95+% | 80125-14-0 | 1g | $947 | 2021-12-16 | Buy |
Remoxipride Chemical Properties,Uses,Production
Uses
Antipsychotic.
Definition
ChEBI: 3-bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2,6-dimethoxybenzamide is a dimethoxybenzene.
General Description
Remoxipride is a D2 receptorblocker.It is as effective as haloperidol with fewer EPS andautonomic side effects. Negative symptoms of schizophreniaare diminished. The drug is classed as an atypical antipsychotic.Life-threatening aplastic anemia was reported with itsuse, which prompted its withdrawal from the market.
With respect to the atypical antipsychotics, two eventslong in the past may shed some light on the events of today.
The field of reuptake-inhibiting antidepressants arose whenonly a very small structural change was made in an antipsychoticdrug, and the new activity noted. (The antipsychoticactivity remained.) Therefore, small changes in structurecan produce antipsychotics that are active against depressivesymptoms. Likewise, small changes in structure could provideselectivity among D2 receptors.
Remoxipride Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 47465 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
| Dayang Chem (Hangzhou) Co.,Ltd. | 571-88938639 +8617705817739 | info@dycnchem.com | CHINA | 52867 | 58 |
| Hu Bei Jiutian Bio-medical Technology CO.,Ltd | 027-88013699 17354350817 | Ryan@jiutian-bio.com | China | 7433 | 58 |
| Mainchem Co., Ltd. | +86-0592-6210733 | sale@mainchem.com | China | 32360 | 55 |
| Beijing HuaMeiHuLiBiological Chemical | 010-56205725 | waley188@sohu.com | China | 12338 | 58 |
| Aikon International Limited | 025-58851090 13611564524 | lwan@aikonchem.com | China | 15952 | 58 |
| TargetMol Chemicals Inc. | 4008200310 | marketing@tsbiochem.com | China | 24131 | 58 |
80125-14-0(Remoxipride)Related Search:
1of4